AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05217355 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be injected into the Glabellar line
Study NCT05696223 — intervention group
Intervention type: OTHER
Intervention: Ultrasound
Description: Doppler mesure
Study NCT04574232 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: knee intra-articular infiltration with Triamcinolone acetonide
Description: knee intra-articular intra-articular ultrasound-guided infiltration of Triamcinolone acetonide
Study NCT05287854 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Description: Once the patient is on the operating table, the nurse proposes the different possible VR scenarios and installs the RV headset and an audio headset.
Study NCT04886817 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilot Intervention to reduce SSB consumption in children and families
Description: A 6-month intervention based on the use of 4 components: an educational video, provision of a water-promotion toolkit, a mobile phone application (app), and a series of 14 computerized interactive voice response (IVR) phone calls to parents to compare families' SSB's consumption behaviors
Study NCT03596242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SMS System
Description: Participants will receive usual care +SMS texting and phone calls to monitor their blood pressure and medication adherence
Study NCT03596242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: blood pressure control education
Description: standard blood pressure control education given during visits
Study NCT03596242 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: blood pressure control education
Description: standard blood pressure control education given during visits
Study NCT05476510 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Postoperative management
Description: Patients will be administered ibuprofen 400 mgr IV every 8 hours in the postoperative period. Postoperative patient evaluation will be performed by a pain nurse blinded to the procedure. 100 mg tramadol will be performed for rescue analgesia.
Study NCT06090175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Projector colleyscope group
Description: Projector kaleidoscope will be used in children aged 3-6 who are administered inhaler medication.
Study NCT06090175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Matching card group
Description: Matching card will be used in children aged 3-6 who are administered inhaler medication.
Study NCT04678908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB0025
Description: Patients will be assigned to dose regimens in the order of enrollment, and they will receive their assigned fixed dose of HB0025 via intravenous infusion.
Study NCT04692376 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells
Description: Mesenchymal stem cells (MSCs) will be intravenously infused via a central venous catheter(at a dose of 1×10\^6 cells/kg, over 15 mins) weekly. MSCs will be administrated for 8 doses.
Study NCT04692376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucocorticoids
Description: Glucocorticoids (i.e. Methylprednisolone) will be used with an initial dose of 1mg/kg.
Study NCT04692376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Description: Glucocorticoids (i.e. Methylprednisolone) will be used with an initial dose of 1mg/kg.
Study NCT04692376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclosporine
Description: Cyclosporine (CsA) will be used with an initial dose of 2.5mg/kg/d and adjusted according to the concentration of CsA. The targeted concentration is 200-300 ng/Ml.
Study NCT04692376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclosporine
Description: Cyclosporine (CsA) will be used with an initial dose of 2.5mg/kg/d and adjusted according to the concentration of CsA. The targeted concentration is 200-300 ng/Ml.
Study NCT06198699 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Jing Si Herbal Tea
Description: Consuming Jing Si Herbal Tea for three months; twice per day with each time 14 g of Jing Si Herbal in 600 ml water
Study NCT06198699 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Barley Tea
Description: Consuming Barley Tea for three months; twice per day with each time 600 ml barley tea consumption
Study NCT05439473 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Curalin
Description: Supplement capsules, 2 capsules, 3 times a day after meals. Placebo: matching placebo capsules, 2 capsules, 3 times a day after meals.
Study NCT05439473 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Curalin
Description: Supplement capsules, 2 capsules, 3 times a day after meals. Placebo: matching placebo capsules, 2 capsules, 3 times a day after meals.
Study NCT06402578 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: HbA1c testing
Description: Bloods will be take pre and post 12 week intervention.
Study NCT05720377 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: continuous glucose monitor (Freestyle Libre
Description: 15 minute phone interview by health care provider to assess health goals set at clinic visits.
Study NCT05731505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: theory-based education-consulting
Description: Parents in the study groups were provided with training and support in line with their needs in the educational issues specified in the Family Education-Support Booklet for a Child with Cerebral Palsy. The control group was not trained. Research data were collected using the Child and Parent Information Form, Needs Determination Form, Relaxed Behavior Checklist (KDKL), Quality of Life for Children Parent Form (PIDQ) and Self-Efficacy Scale. The comfort and quality of life of the children in the study group and the self-efficacy of the parents were evaluated before the education, 1 month and 3 months after the education.
Study NCT04732871 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSVPreF3 OA investigational vaccine
Description: RSVPreF3 OA investigational vaccine administered intramuscularly in the deltoid region of the non-dominant arm.
Study NCT05649189 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: telomere length measure
Description: length of telomere between two groups
Study NCT05995847 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harmonica playing program plus basic PR care with routine follow-up
Description: The intervention will last for a total of six months. During this period, patients are expected to play the harmonica daily for 30 minutes, five days a week. Additionally, patients will receive basic pulmonary rehabilitation (PR) care, which includes self-management education, exercise training, and breathing training, as well as routine follow-up. All training sessions are home-based and will take place five days per week for the duration of six months.
Study NCT05995847 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic PR care with routine follow-up
Description: These patients will receive basic pulmonary rehabilitation (PR) care, which includes self-management education, exercise training, and breathing training, as well as routine follow-up. All training sessions are home-based and will take place five days per week for the duration of six months
Study NCT05571826 — intervention group
Intervention type: BEHAVIORAL
Intervention: telerehabilitation
Description: No specific treatments will be applied. The persons who experienced telerehabilitation interventions will be included.
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4578
Description: Specified dose on specified days
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4538
Description: Specified dose on specified days
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Specified dose on specified days
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Specified dose on specified days
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Specified dose on specified days
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium Levofolinate Hydrateb
Description: Specified dose on specified days
Study NCT06547385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Specified dose on specified days
Study NCT06334341 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer-based simulation training for providers
Description: A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention Guide for Healthcare Professional: Discussing Sexual Health with Your Patients, current PrEP information, and the Social Cognitive Theory. This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
Study NCT06334341 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Best Practice Alert
Description: A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
Study NCT05735405 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuropsychological evaluation
Description: Each participant will undergo a complete neuropsychological evaluation, both before and at the end of the clinical trial, with the aim of detecting any changes or improvements.
Study NCT05735405 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BDNF evaluation
Description: During the first and last clinical trial session, each participant will undergo two blood samples, one before and one at the end of the ride, to check levels of Brain Derived Neurotrophic Factor (BDNF).
Study NCT05735405 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pedaling as a moderate intensity aerobic exercise
Description: During each session, each participant will perform 30 minutes of pedaling as a form of moderate intensity physical activity.
Study NCT05735405 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: During each session, each participant will carry out 60 minutes of cognitive training through specific exercises for the attentional, executive and working memory functions.
Study NCT05735405 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: VO2 assessment
Description: To determine the individual moderate intensity for each patient, a VO2 consumption assessment will be made. The examination will be carried out using an exercise bike and a mask for the calculation of metabolic oxygen consumption.~The 3 MET threshold to reach in pedaling will be calculated (to define it of moderate intensity), in order to elicit the release of BDNF.
Study NCT06334341 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIV Risk Assessment
Description: A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
Study NCT06334341 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PrEP Informational Video
Description: A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
Study NCT05436171 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05376020 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Densah Burs
Description: Densah Burs will be used in the intervention group
Study NCT05376020 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Burs
Description: Conventional Burs will be used in the control group
Study NCT05594004 — intervention group
Intervention type: DEVICE
Intervention: Oscillating-rotating electric toothbrush
Description: Oscillating-rotating electric toothbrush used twice daily
Study NCT05594004 — intervention group
Intervention type: DEVICE
Intervention: Sonic electric toothbrush
Description: Sonic electric toothbrush used twice daily
Study NCT05594004 — intervention group
Intervention type: DEVICE
Intervention: Manual toothbrush
Description: Manual toothbrush used twice daily
Study NCT06333782 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental- Genefill Contour®
Description: Genefill Contour® Hyaluronic Acid Injection
Study NCT06333782 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Marketed comparator - Desirial®Plus
Description: DESIRIAL®PLUS Hyaluronic Acid Injection
Study NCT05604807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dementia course with virtual reality
Description: dementia virtual reality activity, intergenerational learning, world café teaching method and community practice
Study NCT05604807 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dementia course with no virtual reality
Description: dementia course, intergenerational learning, world café teaching method and community practice
Study NCT04770870 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hintermann Series H3 Total Ankle Replacement System
Description: Intervention will include receiving the FDA approved Hintermann Series H3 Total Ankle Replacement System, to include a tibial component, a polyethylene inlay, and a talar component.
Study NCT05650541 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CardioPumlonary Management System
Description: The CPM Device measures and trends a variety of physiologic parameters including thoracic impedance, respiration rate, tidal volume, ECG, heart rate, and diastolic heart sounds, all in an unobtrusive patch form factor.
Study NCT05666362 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: benoxinate hydrochloride 0.4% group
Description: They will receive benoxinate hydrochloride 0.4% immediately before fundus
Study NCT05666362 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline 0.9% .
Description: They will receive saline 0.9% before fundus examination in each eye .
Study NCT06367634 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: injection in NLF
Description: TEOSYAL® PureSense ULTRA DEEP is a sterile, transparent, non-pyrogenic, viscoelastic gel made of HA of non-animal origin
Study NCT06367634 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: injection in NLF
Description: TEOSYAL® PureSense ULTRA DEEP is a sterile, transparent, non-pyrogenic, viscoelastic gel made of HA of non-animal origin
Study NCT05629143 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: de-prescription of PPI via intermittent scheme
Description: The patients will decrease their intake of PPIs via a de-prescription intermittent scheme. After one month, patients will stop their intake of PPI.
Study NCT05629143 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: de-prescription of PPI via on-demand scheme
Description: The patients will decrease their intake of PPIs via a de-prescription on-demand scheme. After one month, patients will stop their intake of PPI.
Study NCT05629143 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Alginate
Description: The patients will stop their intake of PPIs and use alginate. After one month, patients will stop their intake of alginates.
Study NCT05673733 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scapular stabilization exercises with exergaming training
Description: Group A will receive scapular stabilization exercises with exergaming training
Study NCT05673733 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exergaming training
Description: Group B will receive only exergaming training
Study NCT06277180 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Surgery is performed based on the lesion range revealed by 68Ga-TCR-FAPI PET/CT, and all 68Ga-TCR-FAPI-avid lesions are resected.
Study NCT06277180 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: 68Ga-TCR-FAPI PET/CT identified distant metastasis or unresectable lesions, but the patient is still recommended to undergo surgery for debulking or reduce symptoms.
Study NCT05317507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD oil
Description: 50 mg
Study NCT05317507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD oil
Description: 100 mg CBD
Study NCT05317507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT04657575 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Narcotrend
Description: ECT stimulation within an anaesthesia depth range of 41-64
Study NCT06445582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: [18F]SDM-8
Description: synaptic vesicle glycoprotein 2 A（SV2A）PET tracer \[18F\]SDM-8
Study NCT04893187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SSS17
Description: SSS17 is a novel small molecule compound which stimulates erythropoiesis through inhibition of hypoxiainducible factor- prolyl hydroxylases( HIF-PH). It is being developed for the treatment of anemia in patients with chronic kidney disease.
Study NCT04893187 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo.
Study NCT06046209 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control Lens
Description: Daily disposable contact lens for 90 minutes
Study NCT06046209 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Monthly replacement contact lens for 90 minutes
Study NCT06509347 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preassure release
Description: Preassure release in Flexor digitorum brevis trigger point muscle.
Study NCT06509347 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Non-emision laser
Description: Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle
Study NCT05223166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pitolisant
Description: Wakix tablet
Study NCT05223166 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Matching placebo tablets will be provided for each strength of active pitolisant film-coated tablets.
Study NCT05968690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Propranolol will be administered to patients in all cohorts.
Study NCT05968690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone
Description: Naltrexone will be administered to patients in cohorts 2, 3, and 4.
Study NCT05683951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWKH
Description: Administration of DWKH three times daily
Study NCT06489275 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Building Financial Wellness
Description: In addition to receiving services as usual, subjects attend financial literacy classes and booster sessions.
Study NCT06489275 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Services as Usual
Description: Subjects continue to receive services as usual.
Study NCT05683951 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DWKH-R
Description: Administration of DWKH-R three times daily
Study NCT05683951 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of Placebo three times daily
Study NCT03489122 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: yoga
Description: The yoga intervention consists of Iyengar yoga method and coherent breathing sessions for 90 minutes twice a week or a maximum of 24 interventions over the 12 week intervention.
Study NCT03489122 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: walking
Description: The walking intervention consists of walking sessions at 2.5 miles an hour on a flat surface for 60 minutes twice a week or a maximum of 24 interventions over the 12 week intervention.
Study NCT04775719 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patient-Specific Prediction of Functional Outcome
Description: Information sheet that describes whether a patient is more likely to improve on or maintain their current preoperative function.
Study NCT04775719 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Pre-Operative Total Knee Arthroplasty Information
Description: Standard of care information that is routinely provided at patient preadmission appointments.
Study NCT04848753 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Toripalimab combined with cisplatin and paclitaxel
Description: Specified doses on specified days.
Study NCT04848753 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo combined with cisplatin and paclitaxel
Description: Specified doses on specified days.